Reply to “Reversible Cerebral Vasoconstriction Syndrome Responsive to Intravenous Milrinone”
Neurocritical Care - United States
doi 10.1007/s12028-019-00893-3
Full Text
Open PDFAbstract
Available in full text
Date
December 20, 2019
Authors
Publisher
Springer Science and Business Media LLC